T1	AdverseReaction 50 65	Endophthalmitis
T2	AdverseReaction 70 89	retinal detachments
T3	Factor 90 93	may
T7	AdverseReaction 302 335	Increases in intraocular pressure
T8	AdverseReaction 439 469	arterial thromboembolic events
T12	AdverseReaction 658 673	endophthalmitis
T13	AdverseReaction 678 697	retinal detachments
T18	AdverseReaction 1094 1133	Acute increases in intraocular pressure
T19	AdverseReaction 1249 1292	Sustained increases in intraocular pressure
T21	AdverseReaction 1628 1658	arterial thromboembolic events
T22	AdverseReaction 1660 1664	ATEs
T23	Factor 1620 1624	risk
T29	AdverseReaction 1880 1901	thromboembolic events
T30	AdverseReaction 2414 2435	thromboembolic events
T31	Negation 2402 2404	no
T4	DrugClass 500 515	VEGF inhibitors
T5	DrugClass 1357 1391;1399 1409	vascular endothelial growth factor inhibitors
E1	AdverseReaction:T1 Hypothetical:E3
E2	AdverseReaction:T2 Hypothetical:E3
E3	Factor:T3
E7	AdverseReaction:T7
E8	AdverseReaction:T8 Hypothetical2:E4
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E18	AdverseReaction:T18
E19	AdverseReaction:T19 Hypothetical:E5
E21	AdverseReaction:T21 Hypothetical:E23
E22	AdverseReaction:T22 Hypothetical:E23
E23	Factor:T23
E29	AdverseReaction:T29
E30	AdverseReaction:T30 Negated:E31
E31	Negation:T31
E4	DrugClass:T4
E5	DrugClass:T5
A1	CUI E1 C0014236
A2	UMLS-Preferred-Name E1 Endophthalmitis
A3	MEDDRA-PT E1 Endophthalmitis
A4	MEDDRA-PT-ID E1 10014801
A5	CUI E2 C0035305
A6	UMLS-Preferred-Name E2 Retinal Detachment
A7	MEDDRA-PT E2 Retinal detachment
A8	MEDDRA-PT-ID E2 10038848
A9	CUI E7 C0234708
A10	UMLS-Preferred-Name E7 Raised intraocular pressure
A11	MEDDRA-PT E7 Intraocular pressure increased
A12	MEDDRA-PT-ID E7 10022806
A13	LLT E7 Increased intraocular pressure
A14	LLT-ID E7 10021667
A15	CUI E8 C3544094
A16	UMLS-Preferred-Name E8 Arterial thromboembolism
A17	MEDDRA-PT E8 Embolism arterial
A18	MEDDRA-PT-ID E8 10014513
A19	LLT E8 Arterial thromboembolism
A20	LLT-ID E8 10073529
A21	CUI E12 C0014236
A22	UMLS-Preferred-Name E12 Endophthalmitis
A23	MEDDRA-PT E12 Endophthalmitis
A24	MEDDRA-PT-ID E12 10014801
A25	CUI E13 C0035305
A26	UMLS-Preferred-Name E13 Retinal Detachment
A27	MEDDRA-PT E13 Retinal detachment
A28	MEDDRA-PT-ID E13 10038848
A29	CUI E18 C3805171
A30	UMLS-Preferred-Name E18 Acute intraocular pressure increase
A31	MEDDRA-PT E18 Intraocular pressure increased
A32	MEDDRA-PT-ID E18 10022806
A33	LLT E18 Acute intraocular pressure increase
A34	LLT-ID E18 10074448
A35	flag E19 underspecified
A36	CUI E19 C0234708
A37	UMLS-Preferred-Name E19 Raised intraocular pressure
A38	MEDDRA-PT E19 Intraocular pressure increased
A39	MEDDRA-PT-ID E19 10022806
A40	CUI E21 C3544094
A41	UMLS-Preferred-Name E21 Arterial thromboembolism
A42	MEDDRA-PT E21 Embolism arterial
A43	MEDDRA-PT-ID E21 10014513
A44	LLT E21 Arterial thromboembolism
A45	LLT-ID E21 10073529
A46	CUI E22 C3544094
A47	UMLS-Preferred-Name E22 Arterial thromboembolism
A48	MEDDRA-PT E22 Embolism arterial
A49	MEDDRA-PT-ID E22 10014513
A50	LLT E22 Arterial thromboembolism
A51	LLT-ID E22 10073529
A52	CUI E29 C0040038
A53	UMLS-Preferred-Name E29 Thromboembolism
A54	MEDDRA-PT E29 Embolism
A55	MEDDRA-PT-ID E29 10061169
A56	LLT E29 Thromboembolic event
A57	LLT-ID E29 10043565
A58	CUI E30 C0040038
A59	UMLS-Preferred-Name E30 Thromboembolism
A60	MEDDRA-PT E30 Embolism
A61	MEDDRA-PT-ID E30 10061169
A62	LLT E30 Thromboembolic event
A63	LLT-ID E30 10043565
